According to the latest report published by Data Bridge Market Research, the Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors Therapeutics Market
The global glycogen synthase kinase 3 beta (GSK-3β) inhibitors therapeutics market size was valued at USD 2.19 billion in 2024 and is projected to reach USD 3.29 billion by 2032, with a CAGR of 5.20% during the forecast period...